Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

北京沙东生物技术有限公司成立于2001年5月17日,由数名旅美青年科学家共同创立,由国外著名的风险投资公司投资,注册于北京中关村科技园区的高新技术企业。沙东生物是一家专注于基因工程抗肿瘤药物研发与生产的高新技术企业。公司核心产品为国家I类新药“注射用重组变构人肿瘤坏死因子相关凋亡诱导配体”(简称CPT,商品名:沙艾特®),属于靶向基因工程抗肿瘤新药。该药已获国家药监局批准上市,用于治疗复发或难治性多发性骨髓瘤,是全球*获批上市的DR4/DR5激动剂。同时,沙东生物在多个领域同国外实验室进行了密切合作,在技术上同欧美国家保持同步。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

沙东生物 Financing History (1 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 5108万人民币
  • Investor: 海特生物

沙东生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

沙东生物 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,293.8792万(元)
Legal Representative: 陈亚
Date Established:
Credit Code: 91110302726341381X
Registered Address: 北京市门头沟区美安路7号院1号楼4层401室

Partners & Suppliers

海特生物委托北京沙东生物进行注射用重组人白细胞介素-12等创新生物药的临床前及临床研究,北京沙东提供研发服务。 Source
合作客户 生物药合作研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates